Tendon Tissue Engineering is a multidisciplinary field focused on developing innovative strategies to repair or replace damaged tendon tissue using a combination of cells, biomaterial scaffolds, and bioactive factors. Tendons, critical for transmitting forces between muscles and bones, often face challenges in healing due to their limited vascularity and slow cell turnover. Tendon tissue engineering aims to address these limitations by creating functional, biocompatible substitutes. The process typically involves isolating tenocytes or tendon progenitor cells, seeding them onto biodegradable scaffolds that mimic the tendon's extracellular matrix (ECM), and providing appropriate biochemical signals for cell proliferation and matrix synthesis. Various biomaterials, such as hydrogels and electrospun fibers, are employed to create scaffolds with optimal mechanical properties. Additionally, growth factors and mechanical stimulation are integrated to enhance cell differentiation and tissue maturation. Successful tendon tissue engineering endeavors to replicate the native tendon's biomechanical strength, flexibility, and functionality. This approach holds promise for treating tendon injuries, degenerative conditions, and providing alternatives to traditional tendon grafts. Researchers continually refine techniques and explore new materials to improve the efficacy and clinical applicability of tendon tissue engineering, offering potential breakthroughs in regenerative medicine for musculoskeletal disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy